Erlotinib - analogs
Components: Erlotinib |
|||||||||
Pharmgroups: Antitumor agents - protein kinase inhibitors |
|||||||||
Prices in pharmacies: — Instructions Erlotinib | |||||||||
|
ⓘ✘Enter drugs for проверки взаимодействовий through a quick button search . Alvityl Defenses Tablets ✘ (incl) BLOGIR-3 ✘ (incl) Respikam ✘ (incl) Актиферт-Гино ✘ (incl) Klapitaks ✘ (incl) Vaccine influenza virus inactivated+Azoximer bromide ✘ (incl) Ultralan ✘ (incl) Кедровое масло ✘ (incl) Succinum purum ✘ (incl) Lithium carbonate filmcoated tablets ✘ (incl) Dusopharm ✘ (incl) Суперантитокс-50 ✘ (incl) Thymostimulin ✘ (incl) Euphorbia cyparissias ✘ (incl) Flexid ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. |
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Similar | Complete analog ⓘ✘Аналоги препарата с полностью совпадающими действующими веществами |
Prices in pharmacies |
≈100% | Tarceva neutral | 838€ |
≈100% | Tarlenib neutral | — |
≈100% | Erlotinib - native neutral | — |
≈100% | Erlotinib hydrochloride neutral | — |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 67% 2103.9€ Mekinist neutral [Trametinib]
- 64% 862.9€ Vargatef neutral [Nintedanib]
- 59% 2535.2€ Alecensa neutral [Alectinib]
- 55% 2016.2€ Sunitinib-nativ neutral [Sunitinib]
- 55% — Sunitinib neutral [Sunitinib]
- 52% — Verzenio neutral [Abemaciclib]
- 50% 5550€ Tagrisso neutral [Osimertinib]
- 50% 250-450€ Opdivo Negative 🔍 [Nivolumab]
- 50% 637.5-902.1€ Giotrif neutral [Afatinib]
- 50% — Zykadia neutral [Ceritinib]
- 50% — Осимертиниба мезилат neutral [Osimertinib]
- 50% — Осимертиниб neutral [Osimertinib]
- 45% 9.4-25.8€ Vinelbine Negative 🔍 [Vinorelbine]
- 45% 3936.6€ Кабометикс neutral [Cabozantinib]
- 45% — Лорвиква neutral [Lorlatinib]
- 43% — Сунитиниба малат neutral [Sunitinib]
- 43% 1732.5€ Lenvima neutral [Lenvatinib]
- 42% — Sorafenib neutral [Sorafenib]
- 42% — Vincatera Negative 🔍 [Vinorelbine]
- 41% 830-1485.8€ Nexavar neutral [Sorafenib]
- 41% — Флутриксан neutral [Sorafenib]
- 41% — Сорафениб-АМЕДАРТ neutral [Sorafenib]
- 41% — Сорафениб-натив neutral [Sorafenib]
- 41% — Сорафениб геми-тозилат моногидрат neutral [Sorafenib]
- 41% — Сорафениба тозилат neutral [Sorafenib]
- 41% 4-22.5€ Vinorelbine -Teva Negative 🔍 [Vinorelbine]
- 41% — Сорафениб-промомед neutral [Sorafenib]
- 41% 15.5-57.5€ Cytuvin Negative 🔍 [Vinorelbine]
- 41% 46.5€ Maverex Negative 🔍 [Vinorelbine]
- 41% 32.3-50.9€ Navelbine Negative 🔍 [Vinorelbine]
- 40% 1114€ Iressa neutral [Gefitinib]
- 40% 807.2-809.8€ Итулси neutral [Palbociclib]
- 40% 798-825€ Ibrance neutral [Palbociclib]
- 40% — Gefitinib neutral [Gefitinib]
- 38% 40€ Velbin Negative 🔍 [Vinorelbine]
- 38% — Vinorelbine Kelun-Kazpharm Negative 🔍 [Vinorelbine]
- 36% — Pemetrexed-TL Negative 🔍 [Pemetrexed]
- 36% 447.2-480€ Alimta Negative 🔍 [Pemetrexed]
- 36% — Пемджем Negative 🔍 [Pemetrexed]
- 36% 76.2-377.7€ Пемелан Negative 🔍 [Pemetrexed]
- 36% — Фолитрекс Negative 🔍 [Pemetrexed]
- 36% — Пеметрексед Канон Negative 🔍 [Pemetrexed]
- 36% 407.7€ Pemetrexed Negative 🔍 [Pemetrexed]
- 36% — Пеметрекседа динатрия гептагидрат Negative 🔍 [Pemetrexed]
- 36% — Pemetrexed disodium Negative 🔍 [Pemetrexed]
- 36% — Pemetrexed J Negative 🔍 [Pemetrexed]
- 36% — Антифолат Negative 🔍 [Pemetrexed]
- 36% — Пеметрексед-промомед Negative 🔍 [Pemetrexed]
- 36% — Pemetrexed-nativ Negative 🔍 [Pemetrexed]
- 36% — Пеметрексед-Келун-Казфарм Negative 🔍 [Pemetrexed]
Learn more about the selection of analogues
- The drug has «Erlotinib» 6 full analogs, the cheapest - Tarceva (838€); 51 analog by action, the most similar - Mekinist (2103.9€).
- Medical online service has selected the best substitutes for Erlotinib based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of Erlotinib analogues to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.